Sana Biotechnology Inc (SANA) concluded trading on Wednesday at a closing price of $7.22, with 3.87 million shares of worth about $27.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 34.20% during that period and on Wednesday the price saw a gain of about 15.15%. Currently the company’s common shares owned by public are about 191.02M shares, out of which, 108.54M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 20 times over the past 12 months. They bought 24,429 shares in 6 of the transactions. In 14 selling transactions, insiders dumped 12,526,517 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stock saw a price change of 18.36% in past 5 days and over the past one month there was a price change of 13.52%. Year-to-date (YTD), SANA shares are showing a performance of 76.96% which increased to 68.69% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.74 but also hit the highest price of $9.15 during that period. The average intraday trading volume for Sana Biotechnology Inc shares is 3.07 million. The stock is currently trading 24.46% above its 20-day simple moving average (SMA20), while that difference is up 43.39% for SMA50 and it goes to 41.84% higher than SMA200.
Sana Biotechnology Inc (NASDAQ: SANA) currently have 191.02M outstanding shares and institutions hold larger chunk of about 43.29% of that.
The stock has a current market capitalization of $1.55B and its 3Y-monthly beta is at 1.27. It has posted earnings per share of -$1.44 in the same period. It has Quick Ratio of 4.19 while making debt-to-equity ratio of 0.26. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SANA, volatility over the week remained 11.25% while standing at 9.23% over the month.
Analysts are in expectations that Sana Biotechnology Inc (SANA) stock would likely to be making an EPS of $Sandstorm Gold Ltd. in the current quarter, while forecast for next quarter EPS is $3.98 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Sana Biotechnology, Inc. which is $Snap-On Incorporated at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Banco Santander, S.A. Sponsored in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 14.99% while it is estimated to increase by 27.80% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on January 16, 2024 offering a Buy rating for the stock and assigned a target price of $12 to it.
